176 related articles for article (PubMed ID: 9450511)
21. Carbon-11-cocaine binding compared at subpharmacological and pharmacological doses: a PET study.
Volkow ND; Fowler JS; Logan J; Gatley SJ; Dewey SL; MacGregor RR; Schlyer DJ; Pappas N; King P; wang GJ
J Nucl Med; 1995 Jul; 36(7):1289-97. PubMed ID: 7790958
[TBL] [Abstract][Full Text] [Related]
22. [(11)]Cocaine: PET studies of cocaine pharmacokinetics, dopamine transporter availability and dopamine transporter occupancy.
Fowler JS; Volkow ND; Wang GJ; Gatley SJ; Logan J
Nucl Med Biol; 2001 Jul; 28(5):561-72. PubMed ID: 11516700
[TBL] [Abstract][Full Text] [Related]
23. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
Kilbourn MR; Kuszpit K; Sherman P
Synapse; 2000 Mar; 35(4):250-5. PubMed ID: 10657034
[TBL] [Abstract][Full Text] [Related]
24. Comparable changes in synaptic dopamine induced by methylphenidate and by cocaine in the baboon brain.
Volkow ND; Fowler JS; Gatley SJ; Dewey SL; Wang GJ; Logan J; Ding YS; Franceschi D; Gifford A; Morgan A; Pappas N; King P
Synapse; 1999 Jan; 31(1):59-66. PubMed ID: 10025684
[TBL] [Abstract][Full Text] [Related]
25. Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations.
Villemagne V; Yuan J; Wong DF; Dannals RF; Hatzidimitriou G; Mathews WB; Ravert HT; Musachio J; McCann UD; Ricaurte GA
J Neurosci; 1998 Jan; 18(1):419-27. PubMed ID: 9412518
[TBL] [Abstract][Full Text] [Related]
26. Sensitivity of striatal [11C]cocaine binding to decreases in synaptic dopamine.
Gatley SJ; Volkow ND; Fowler JS; Dewey SL; Logan J
Synapse; 1995 Jun; 20(2):137-44. PubMed ID: 7570343
[TBL] [Abstract][Full Text] [Related]
27. Measurement of dopamine transporter occupancy for multiple injections of cocaine using a single injection of [F-18]FECNT.
Votaw JR; Howell LL; Martarello L; Hoffman JM; Kilts CD; Lindsey KP; Goodman MM
Synapse; 2002 Jun; 44(4):203-10. PubMed ID: 11984856
[TBL] [Abstract][Full Text] [Related]
28. Understanding the central pharmacokinetics of spheroidal oral drug absorption system (SODAS) dexmethylphenidate: a positron emission tomography study of dopamine transporter receptor occupancy measured with C-11 altropane.
Spencer TJ; Bonab AA; Dougherty DD; Mirto T; Martin J; Clarke A; Fischman AJ
J Clin Psychiatry; 2012 Mar; 73(3):346-52. PubMed ID: 22154896
[TBL] [Abstract][Full Text] [Related]
29. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications.
Volkow ND; Wang GJ; Fowler JS; Logan J; Franceschi D; Maynard L; Ding YS; Gatley SJ; Gifford A; Zhu W; Swanson JM
Synapse; 2002 Mar; 43(3):181-7. PubMed ID: 11793423
[TBL] [Abstract][Full Text] [Related]
30. Long-lasting inhibition of in vivo cocaine binding to dopamine transporters by 3 beta-(4-iodophenyl)tropane-2-carboxylic acid methyl ester: RTI-55 or beta CIT.
Volkow ND; Gatley SJ; Fowler JS; Chen R; Logan J; Dewey SL; Ding YS; Pappas N; King P; MacGregor RR
Synapse; 1995 Mar; 19(3):206-11. PubMed ID: 7784960
[TBL] [Abstract][Full Text] [Related]
31. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain.
Volkow ND; Ding YS; Fowler JS; Wang GJ; Logan J; Gatley JS; Dewey S; Ashby C; Liebermann J; Hitzemann R
Arch Gen Psychiatry; 1995 Jun; 52(6):456-63. PubMed ID: 7771915
[TBL] [Abstract][Full Text] [Related]
32. Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters.
Fischman AJ; Bonab AA; Babich JW; Palmer EP; Alpert NM; Elmaleh DR; Callahan RJ; Barrow SA; Graham W; Meltzer PC; Hanson RN; Madras BK
Synapse; 1998 Jun; 29(2):128-41. PubMed ID: 9593103
[TBL] [Abstract][Full Text] [Related]
33. Dopamine transporter: transmembrane phenylalanine mutations can selectively influence dopamine uptake and cocaine analog recognition.
Lin Z; Wang W; Kopajtic T; Revay RS; Uhl GR
Mol Pharmacol; 1999 Aug; 56(2):434-47. PubMed ID: 10419565
[TBL] [Abstract][Full Text] [Related]
34. SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT.
Abi-Dargham A; Gandelman MS; DeErausquin GA; Zea-Ponce Y; Zoghbi SS; Baldwin RM; Laruelle M; Charney DS; Hoffer PB; Neumeyer JL; Innis RB
J Nucl Med; 1996 Jul; 37(7):1129-33. PubMed ID: 8965183
[TBL] [Abstract][Full Text] [Related]
35. A new PET ligand for the dopamine transporter: studies in the human brain.
Volkow ND; Ding YS; Fowler JS; Wang GJ; Logan J; Gatley SJ; Schlyer DJ; Pappas N
J Nucl Med; 1995 Dec; 36(12):2162-8. PubMed ID: 8523098
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of [11C]RTI-121 as a selective radioligand for PET studies of the dopamine transporter.
Hume SP; Luthra SK; Brown DJ; Opacka-Juffry J; Osman S; Ashworth S; Myers R; Brady F; Carroll FI; Kuhar MJ; Brooks DJ
Nucl Med Biol; 1996 Apr; 23(3):377-84. PubMed ID: 8782251
[TBL] [Abstract][Full Text] [Related]
37. Displacement of RTI-55 from the dopamine transporter by cocaine.
Gatley SJ; Volkow ND; Chen R; Fowler JS; Carroll FI; Kuhar MJ
Eur J Pharmacol; 1996 Jan; 296(2):145-51. PubMed ID: 8838450
[TBL] [Abstract][Full Text] [Related]
38. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
[TBL] [Abstract][Full Text] [Related]
39. A reduced rate of in vivo dopamine transporter binding is associated with lower relative reinforcing efficacy of stimulants.
Wee S; Carroll FI; Woolverton WL
Neuropsychopharmacology; 2006 Feb; 31(2):351-62. PubMed ID: 15957006
[TBL] [Abstract][Full Text] [Related]
40. PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter.
Helfenbein J; Sandell J; Halldin C; Chalon S; Emond P; Okubo Y; Chou YH; Frangin Y; Douziech L; Gareau L; Swahn CG; Besnard JC; Farde L; Guilloteau D
Nucl Med Biol; 1999 Jul; 26(5):491-9. PubMed ID: 10473187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
